Glycogen as a Putative Target for Diagnosis and Therapy in Brain Pathologies
ISRN Pathology · 2011
DOI: 10.5402/2011/930729 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Pathology, 2011. Verfasst von Jean-François Cloix und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Brain glycogen, a glucose polymer, is now considered as a functional energy store to the brain. Indeed, when neurons outpace their own possibilities to provide themselves with energy, astrocytic metabolism is in charge of feeding neurons, since brain glycogen synthesis is mainly due to astrocyte. Therefore, malfunctions or perturbations of astrocytic glycogen content, synthesis, or mobilization may be involved in processes of brain pathologies. This is the case, for example, in epilepsies and gliomas, two different situations in which, brain needs high level of energy during acute or chronic conditions. The purpose of the present paper is to demonstrate how brain glycogen might be relevant in these two pathologies and to pinpoint the possibilities of considering glycogen as a tool for diagnostic and therapeutic approaches in brain pathologies.
Zitieren
APA
Cloix, J., & Hévor, T. (2011). Glycogen as a Putative Target for Diagnosis and Therapy in Brain Pathologies. ISRN Pathology. https://doi.org/10.5402/2011/930729
Vancouver
Cloix J, Hévor T. Glycogen as a Putative Target for Diagnosis and Therapy in Brain Pathologies. ISRN Pathology. 2011. doi:10.5402/2011/930729
BibTeX
@article{Cloix2011,
author = {Cloix, Jean-François and Hévor, Tobias},
title = {Glycogen as a Putative Target for Diagnosis and Therapy in Brain Pathologies},
journal = {ISRN Pathology},
year = {2011},
doi = {10.5402/2011/930729}
}
EUVIMED